These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 35757923)
61. Animal Models for the Study of SARS-CoV-2-Induced Respiratory Disease and Pathology. Dillard JA; Martinez SA; Dearing JJ; Montgomery SA; Baxter VK Comp Med; 2023 Feb; 73(1):72-90. PubMed ID: 36229170 [TBL] [Abstract][Full Text] [Related]
62. Structural and functional modelling of SARS-CoV-2 entry in animal models. Brooke GN; Prischi F Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513 [TBL] [Abstract][Full Text] [Related]
63. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Shi J; Wen Z; Zhong G; Yang H; Wang C; Huang B; Liu R; He X; Shuai L; Sun Z; Zhao Y; Liu P; Liang L; Cui P; Wang J; Zhang X; Guan Y; Tan W; Wu G; Chen H; Bu Z Science; 2020 May; 368(6494):1016-1020. PubMed ID: 32269068 [TBL] [Abstract][Full Text] [Related]
64. Hamster models of COVID-19 pneumonia reviewed: How human can they be? Gruber AD; Firsching TC; Trimpert J; Dietert K Vet Pathol; 2022 Jul; 59(4):528-545. PubMed ID: 34856819 [TBL] [Abstract][Full Text] [Related]
65. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108 [TBL] [Abstract][Full Text] [Related]
66. SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface. Sharun K; Tiwari R; Saied AA; Dhama K Vaccine; 2021 Dec; 39(49):7119-7122. PubMed ID: 34782159 [TBL] [Abstract][Full Text] [Related]
67. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
68. Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19. Robertson SJ; Bedard O; McNally KL; Shaia C; Clancy CS; Lewis M; Broeckel RM; Chiramel AI; Shannon JG; Sturdevant GL; Rosenke R; Anzick SL; Forte E; Preuss C; Baker CN; Harder JM; Brunton C; Munger S; Bruno DP; Lack JB; Leung JM; Shamsaddini A; Gardina P; Sturdevant DE; Sun J; Martens C; Holland SM; Rosenthal NA; Best SM Nat Commun; 2023 Jul; 14(1):4481. PubMed ID: 37491352 [TBL] [Abstract][Full Text] [Related]
69. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets. Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487 [TBL] [Abstract][Full Text] [Related]
70. Roborovski hamster Zhai C; Wang M; Chung HJ; Hassan M; Lee S; Kim HJ; Hong ST Virulence; 2021 Dec; 12(1):2430-2442. PubMed ID: 34517779 [TBL] [Abstract][Full Text] [Related]
71. K18-hACE2 mice develop respiratory disease resembling severe COVID-19. Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158 [TBL] [Abstract][Full Text] [Related]
72. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. To KK; Sridhar S; Chiu KH; Hung DL; Li X; Hung IF; Tam AR; Chung TW; Chan JF; Zhang AJ; Cheng VC; Yuen KY Emerg Microbes Infect; 2021 Dec; 10(1):507-535. PubMed ID: 33666147 [TBL] [Abstract][Full Text] [Related]
73. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection. Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828 [TBL] [Abstract][Full Text] [Related]
74. Animal Models to Study Emerging Technologies Against SARS-CoV-2. Mullick JB; Simmons CS; Gaire J Cell Mol Bioeng; 2020 Aug; 13(4):293-303. PubMed ID: 32837584 [TBL] [Abstract][Full Text] [Related]
75. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2. Braxton AM; Creisher PS; Ruiz-Bedoya CA; Mulka KR; Dhakal S; Ordonez AA; Beck SE; Jain SK; Villano JS Comp Med; 2021 Oct; 71(5):398-410. PubMed ID: 34588095 [TBL] [Abstract][Full Text] [Related]
76. Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans. Saif LJ; Jung K J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32522830 [TBL] [Abstract][Full Text] [Related]
77. Coronaviruses Associated with the Superfamily Stout AE; Guo Q; Millet JK; de Matos R; Whittaker GR mBio; 2021 Jan; 12(1):. PubMed ID: 33468694 [TBL] [Abstract][Full Text] [Related]
78. SARS-CoV-2 in animals: From potential hosts to animal models. Michelitsch A; Wernike K; Ulrich L; Mettenleiter TC; Beer M Adv Virus Res; 2021; 110():59-102. PubMed ID: 34353482 [TBL] [Abstract][Full Text] [Related]
79. Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model. Kreft IC; Winiarczyk RRA; Tanis FJ; van der Zwaan C; Schmitz KS; Hoogendijk AJ; de Swart RL; Moscona A; Porotto M; Salvatori DCF; de Vries RD; de Maat MPM; van den Biggelaar M; van Vlijmen BJM; Thromb Res; 2022 Feb; 210():6-11. PubMed ID: 34954402 [TBL] [Abstract][Full Text] [Related]